CDK9 is a prognostic marker and therapeutic target in pancreatic cancer
Despite recent advances in diagnosis and therapy, prognosis of pancreatic cancer still remains very poor. Besides valid prognostic markers, novel therapeutic approaches are urgently needed. The family of cyclin-dependent kinases comprises 20 kinases which contribute to malignancy by promoting prolif...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-02-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317694304 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|